Deutsche Bank’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-392,764
Closed -$327K 4833
2021
Q2
$327K Buy
+392,764
New +$366K ﹤0.01% 3493
2020
Q1
Sell
-2,686
Closed 5108
2019
Q4
$0 Sell
2,686
-13,254
-83% -$4.46K ﹤0.01% 5224
2019
Q3
$5K Buy
15,940
+6,271
+65% +$1.95K ﹤0.01% 4675
2019
Q2
$2K Sell
9,669
-43,227
-82% -$13.1K ﹤0.01% 5203
2019
Q1
$17K Sell
52,896
-380
-0.7% -$335 ﹤0.01% 4824
2018
Q4
$64K Sell
53,276
-39,939
-43% -$63.3K ﹤0.01% 4380
2018
Q3
$174K Buy
93,215
+17,508
+23% +$37.5K ﹤0.01% 4294
2018
Q2
$170K Buy
75,707
+48,628
+180% +$97.6K ﹤0.01% 4350
2018
Q1
$59K Buy
+27,079
New +$55.6K ﹤0.01% 4703

Other funds holding ZOM

Deutsche Bank's ZOM Position: Q3 2021 in Review

Deutsche Bank sold out of Zomedica Corp. (ZOM) in Q3 2021, closing a stake of 392,764 shares — an estimated $327K sold.

Deutsche Bank first reported a position in ZOM in Q1 2018 and held it in 9 quarters. The position peaked at $327K in Q2 2021. 107 funds tracked by Wall St. Rank hold ZOM as of Q3 2021.

  • Deutsche Bank reported no remaining Zomedica Corp. position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 392,764 Zomedica Corp. shares in Q3 2021, an estimated $327K.
  • Deutsche Bank first reported a position in Zomedica Corp. in Q1 2018 and held it in 9 quarters.
  • Deutsche Bank's Zomedica Corp. position peaked at $327K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.